BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1279 related articles for article (PubMed ID: 16533397)

  • 1. Select estrogens within the complex formulation of conjugated equine estrogens (Premarin) are protective against neurodegenerative insults: implications for a composition of estrogen therapy to promote neuronal function and prevent Alzheimer's disease.
    Zhao L; Brinton RD
    BMC Neurosci; 2006 Mar; 7():24. PubMed ID: 16533397
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An estrogen replacement therapy containing nine synthetic plant-based conjugated estrogens promotes neuronal survival.
    Zhao L; Chen S; Brinton RD
    Exp Biol Med (Maywood); 2003 Jul; 228(7):823-35. PubMed ID: 12876302
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estrogens and menopause: pharmacology of conjugated equine estrogens and their potential role in the prevention of neurodegenerative diseases such as Alzheimer's.
    Bhavnani BR
    J Steroid Biochem Mol Biol; 2003 Jun; 85(2-5):473-82. PubMed ID: 12943738
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Equine estrogens differentially prevent neuronal cell death induced by glutamate.
    Bhavnani BR; Berco M; Binkley J
    J Soc Gynecol Investig; 2003 Jul; 10(5):302-8. PubMed ID: 12853093
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of the selective estrogen receptor modulator, tamoxifen, on neuronal outgrowth and survival following toxic insults associated with aging and Alzheimer's disease.
    O'Neill K; Chen S; Diaz Brinton R
    Exp Neurol; 2004 Aug; 188(2):268-78. PubMed ID: 15246826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The women's health initiative estrogen replacement therapy is neurotrophic and neuroprotective.
    Diaz Brinton R; Chen S; Montoya M; Hsieh D; Minaya J; Kim J; Chu HP
    Neurobiol Aging; 2000; 21(3):475-96. PubMed ID: 10858597
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Estrogenic agonist activity of ICI 182,780 (Faslodex) in hippocampal neurons: implications for basic science understanding of estrogen signaling and development of estrogen modulators with a dual therapeutic profile.
    Zhao L; O'Neill K; Brinton RD
    J Pharmacol Exp Ther; 2006 Dec; 319(3):1124-32. PubMed ID: 16951259
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protection of cortical cells by equine estrogens against glutamate-induced excitotoxicity is mediated through a calcium independent mechanism.
    Perrella J; Bhavnani BR
    BMC Neurosci; 2005 May; 6():34. PubMed ID: 15882473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacology of conjugated equine estrogens: efficacy, safety and mechanism of action.
    Bhavnani BR; Stanczyk FZ
    J Steroid Biochem Mol Biol; 2014 Jul; 142():16-29. PubMed ID: 24176763
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neuroprotective and neurotrophic efficacy of phytoestrogens in cultured hippocampal neurons.
    Zhao L; Chen Q; Diaz Brinton R
    Exp Biol Med (Maywood); 2002 Jul; 227(7):509-19. PubMed ID: 12094016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Equine estrogens differentially inhibit DNA fragmentation induced by glutamate in neuronal cells by modulation of regulatory proteins involved in programmed cell death.
    Zhang Y; Lu X; Bhavnani BR
    BMC Neurosci; 2003 Dec; 4():32. PubMed ID: 14693041
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacokinetics and pharmacodynamics of conjugated equine estrogens: chemistry and metabolism.
    Bhavnani BR
    Proc Soc Exp Biol Med; 1998 Jan; 217(1):6-16. PubMed ID: 9421201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen receptor alpha and beta differentially regulate intracellular Ca(2+) dynamics leading to ERK phosphorylation and estrogen neuroprotection in hippocampal neurons.
    Zhao L; Brinton RD
    Brain Res; 2007 Oct; 1172():48-59. PubMed ID: 17803971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gene expression analyses of vitellogenin, choriogenin and estrogen receptor subtypes in the livers of male medaka (Oryzias latipes) exposed to equine estrogens.
    Ishibashi H; Uchida M; Koyanagi A; Kagami Y; Kusano T; Nakao A; Yamamoto R; Ichikawa N; Tominaga N; Ishibashi Y; Arizono K
    J Appl Toxicol; 2016 Nov; 36(11):1392-400. PubMed ID: 26863931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential neuroprotective effects of equine estrogens against oxidized low density lipoprotein-induced neuronal cell death.
    Berco M; Bhavnani BR
    J Soc Gynecol Investig; 2001; 8(4):245-54. PubMed ID: 11525901
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The estrogen replacement therapy of the Women's Health Initiative promotes the cellular mechanisms of memory and neuronal survival in neurons vulnerable to Alzheimer's disease.
    Brinton RD; Chen S; Montoya M; Hsieh D; Minaya J
    Maturitas; 2000 Apr; 34 Suppl 2():S35-52. PubMed ID: 10915920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons.
    Zhao L; Wu TW; Brinton RD
    Brain Res; 2004 Jun; 1010(1-2):22-34. PubMed ID: 15126114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Estradiol prevents amyloid-beta peptide-induced cell death in a cholinergic cell line via modulation of a classical estrogen receptor.
    Marin R; Guerra B; Hernández-Jiménez JG; Kang XL; Fraser JD; López FJ; Alonso R
    Neuroscience; 2003; 121(4):917-26. PubMed ID: 14580942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the antioxidant effects of equine estrogens, red wine components, vitamin E, and probucol on low-density lipoprotein oxidation in postmenopausal women.
    Bhavnani BR; Cecutti A; Gerulath A; Woolever AC; Berco M
    Menopause; 2018 Nov; 25(11):1214-1223. PubMed ID: 30358716
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dose and temporal pattern of estrogen exposure determines neuroprotective outcome in hippocampal neurons: therapeutic implications.
    Chen S; Nilsen J; Brinton RD
    Endocrinology; 2006 Nov; 147(11):5303-13. PubMed ID: 16916950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 64.